Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept. - Wikidata - awgldk - TriplyDB

Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.

Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.

http://www.wikidata.org/entity/Q34004313

about

Does bilingualism contribute to cognitive reserve? Cognitive and neural perspectives Brain imaging in Alzheimer disease PET amyloid-beta imaging in preclinical Alzheimer's disease In vivo assessment of amyloid-β deposition in nondemented very elderly subjects Neuroimaging of dementia in 2013: what radiologists need to know.Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging.Cardiac sympathetic neuroimaging in dementia with lewy bodies Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease Face-name associative memory performance is related to amyloid burden in normal elderly.Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysis.The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease Persistence of Gender Related-Effects on Visuo-Spatial and Verbal Working Memory in Right Brain-Damaged Patients.Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease.Cognitive reserve and clinical expression of Alzheimer's disease: evidence and implications for brain PET imaging.Cognitive Reserve in Healthy Aging and Alzheimer's Disease: A Meta-Analysis of fMRI Studies.Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease.

P2860

Q26864337-89B1DD9E-A9D8-4B27-8918-B15DCBF51547 Q26996299-22613AC1-8DF1-4AC5-B69E-9162A8F43A8F Q30040695-D2861AE5-F0D7-4982-95FD-43A9AAC6DEA5 Q30412704-FE727A7E-E5EC-49EB-A49B-069ED8C8B837 Q30654332-2E8DA9AD-9F26-4B73-9417-38357CC7592C Q33997384-923B9039-894A-4B88-899C-283363D372CF Q34539572-16CC970F-C108-4F1F-AC74-FCC37C03824D Q34646071-D104B079-7A9D-4E1E-91DF-5B0AD04E841D Q35109364-2497B575-CF21-490D-ADA1-C12D1A71B319 Q35600979-6DD5ADC5-18C5-431A-AB4D-3D1DE65C434D Q35744444-814646BA-1E42-4AC1-A235-AFB447971B74 Q35800785-087B1E76-8B15-4F05-80C9-07EEB794B0DC Q36221014-64DC816A-166D-44CA-85BE-B7EEA73A6324 Q36434858-13E8055E-727E-4CF6-AAAF-AB0839D08659 Q36693841-AA484CD8-456E-49C3-8A2E-5E0D9458F015 Q36849128-A00616FF-92D0-4FE9-8A70-7DDC459D2BF6 Q36953075-2F7964C5-281C-43F5-B97C-DC086E3EC41C Q37043202-8C64E228-ED53-4570-9455-A78237392655 Q37689697-871A0D82-F129-43FC-909A-B7FC3C52EB3D Q37825442-63E4F427-0900-4E35-AB0E-1FAE52F12552 Q38209336-BC44B114-A751-472B-899B-3F0C0A91773C Q48673992-8FD5FA81-69C5-4F57-9F68-32A14926EF93 Q48773448-99FFB24A-66B9-499A-BED7-E040214D44C8

P2860

Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.

http://www.wikidata.org/entity/Q34004313

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Alzheimer disease identificati ...... e variables: proof of concept.

@ast

Alzheimer disease identificati ...... e variables: proof of concept.

@en

Alzheimer disease identificati ...... e variables: proof of concept.

@nl

type

label

Alzheimer disease identificati ...... e variables: proof of concept.

@ast

Alzheimer disease identificati ...... e variables: proof of concept.

@en

Alzheimer disease identificati ...... e variables: proof of concept.

@nl

prefLabel

Alzheimer disease identificati ...... e variables: proof of concept.

@ast

Alzheimer disease identificati ...... e variables: proof of concept.

@en

Alzheimer disease identificati ...... e variables: proof of concept.

@nl

P1433

Q34004313-F3938C81-D713-4A0E-A189-579E316C3937

P1476

Q34004313-B8990871-0D3E-45DE-9749-924DD00460FF

P2093

Q34004313-1628BEF9-75A3-413C-9202-B3DCFC0C0A96

Q34004313-1F718159-7171-4634-9E4F-4E224B2DFC6D

Q34004313-2F42892B-E249-4F0C-8189-92792A81382B

Q34004313-38A65DDA-9861-4318-8B29-83F7D257759B

Q34004313-5D55981A-4041-41E5-B982-5F6555981EAE

Q34004313-61430C56-FDB4-45C8-8DD9-41EAA92C2D11

P2860

Q34004313-067B6966-5012-4DA6-9043-D71FFB05E06C

Q34004313-088574F4-D05A-4616-8E17-2EA3962F1CAE

Q34004313-2EBB9C52-8519-4F3F-A5EC-4CD419E74CAC

Q34004313-30039604-6F32-4C14-9C50-26959D9B299A

Q34004313-349E485E-55E0-431A-83AD-88947CFB4A6A

Q34004313-3FE3A5AE-5EC2-4AC0-A77B-14A5B9E9C207

Q34004313-47BADDDE-2436-4E66-BEB3-C72FEB49167C

Q34004313-59F01324-88B5-4CFB-8FF3-3A81FBF6A3DF

Q34004313-605E88D4-94F7-4E25-A7EA-A0D239CFEDEF

Q34004313-7356A2B2-4B6D-4BF3-BAD3-C0BF000AFA0D

P304

Q34004313-A73EBA97-EF8D-4E31-BC7B-38354749E0BA

P31

Q34004313-EFD0BF98-D78F-4852-A2DA-821FA7028A06

P356

Q34004313-AD76BC62-2ED2-4EAF-A3C0-410601320CC8

P407

Q34004313-D0EF6685-8296-48F9-89C8-7BDE52E4045B

P433

Q34004313-3740E67E-2CA5-420E-BF60-2B6B0AF0E384

P478

Q34004313-FE065A28-E1F5-4664-90B9-AA1FF450D5EA

P50

Q34004313-402887B1-89A6-4BF4-827C-B6A3D93F71D9

P577

Q34004313-D5AF6122-C504-47ED-A193-9D5CDAC635A9

P698

Q34004313-AA95E65E-114C-43FC-B2F8-2605B0298318

P921

Q34004313-995E346E-8187-4212-A3BD-42A0F030E42D

Q34004313-AEDE02BD-6268-4D97-AFDC-0FDDBB0C5233

P932

Q34004313-3EA426E0-D9F4-4450-84D6-0CBFF5185057

P356

WNL.0B013E3181E620F4

P1433

P1476

Alzheimer disease identificati ...... e variables: proof of concept.

@en

P2093

C M Roe

http://www.w3.org/2001/XMLSchema#string

D S Marcus

http://www.w3.org/2001/XMLSchema#string

E A Grant

http://www.w3.org/2001/XMLSchema#string

J C Morris

http://www.w3.org/2001/XMLSchema#string

M M Williams

http://www.w3.org/2001/XMLSchema#string

N Ghoshal

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive Reserve and Alzheimer Disease

Distinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological Correlates

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

“Mini-mental state”

Education modifies the relation of AD pathology to level of cognitive function in older persons

Influence of education and occupation on the incidence of Alzheimer's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease

The Clinical Dementia Rating (CDR): current version and scoring rules

P304

42-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3181E620F4

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20603484

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

amyloid imaging

P932

2906402

http://www.w3.org/2001/XMLSchema#string